These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17030732)

  • 21. Complications after photodynamic therapy.
    Schnurrbusch UE; Jochmann C; Einbock W; Wolf S
    Arch Ophthalmol; 2005 Oct; 123(10):1347-50. PubMed ID: 16219725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal response of the retinal pigment epithelium to photodynamic therapy in a child.
    Diaz M; Cervera E; Hernandez M; Salom D
    Retina; 2006 Sep; 26(7):834-6. PubMed ID: 16963864
    [No Abstract]   [Full Text] [Related]  

  • 23. Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks.
    Karadimas P; Bouzas EA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):78-80. PubMed ID: 14750772
    [No Abstract]   [Full Text] [Related]  

  • 24. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 27. Large submacular hemorrhages after verteporfin therapy.
    Do DV; Bressler NM; Bressler SB
    Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H; Gierek-Łapińska A
    Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
    Chaudhry NA; Lavaque AJ; Shah A; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):70-2. PubMed ID: 15688974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient visual disturbance after photodynamic therapy.
    Mennel S; Meyer CH
    Am J Ophthalmol; 2005 Apr; 139(4):748-9; author reply 749. PubMed ID: 15808191
    [No Abstract]   [Full Text] [Related]  

  • 33. Verteporfin in Photodynamic Therapy: report no. 5.
    Bandello F; Blinder K; Bressler NM; Brown AL; Miller JW; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Slakter JS; Soubrane G; Strong HA; Stur M;
    Ophthalmology; 2004 Nov; 111(11):2144. PubMed ID: 15522385
    [No Abstract]   [Full Text] [Related]  

  • 34. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females.
    Postelmans L; Pasteels B; Coquelet P; El Ouardighi H; Verougstraete C; Schmidt-Erfurth U
    Am J Ophthalmol; 2004 Nov; 138(5):803-8. PubMed ID: 15531316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
    Brown DM; Kaiser PK; Michels M; Soubrane G; Heier JS; Kim RY; Sy JP; Schneider S;
    N Engl J Med; 2006 Oct; 355(14):1432-44. PubMed ID: 17021319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exudative complications after photodynamic therapy.
    Holz ER; Linares L; Mieler WF; Weinberg DV
    Arch Ophthalmol; 2003 Nov; 121(11):1649-52. PubMed ID: 14609931
    [No Abstract]   [Full Text] [Related]  

  • 39. Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):475-7. PubMed ID: 14620753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization.
    Bernstein PS; Horn RS
    Retina; 2008 Jan; 28(1):81-4. PubMed ID: 18185142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.